There’s no solid medical knowledge on an outlined withdrawal syndrome from BPC-157, mostly simply because there’s no sound clinical information on Significantly of just about anything with this particular peptide in people. That absence of evidence isn’t the same as an absence of possibility. If BPC-157 does meaningfully interact with dopamin